Skip to main content

Table 2 Dosage schedule for clinical trial

From: An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home

 

Timing

Haloperidol

Olanzapine

First 24 h

First dose

2.5 mg

5.0 mg

12 h later

2.5 mg

5.0 mg

First breakthrough

2.5 mg

5.0 mg

Second breakthrough

2.5 mg

5.0 mg

Second 24 h

First dose

2.5 mg

5.0 mg

12 h later

2.5 mg

5.0 mg

First breakthrough

2.5 mg

5.0 mg

Second breakthrough

2.5 mg

5.0 mg

Third 24 h

First dose

2.5 mg

5.0 mg

12 h later

2.5 mg

5.0 mg

First breakthrough

2.5 mg

5.0 mg

Second breakthrough

2.5 mg

5.0 mg

 

Total dose prepared

30.0 mg (10.0 mg/day)

60.0 mg (20.0 mg/day)